The Latest
Bamlanivimab Plus Etesevimab Authorized for Postexposure Prophylaxis for COVID-19
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
Long-Acting Octreotide Therapy Gets Orphan Drug Status for Polycystic Liver Disease
Oral Inosine Does Not Slow Progression of Early Parkinson Disease
MPR Weekly Dose Podcast Episode 93
Real-Time Mammography Reading Cuts Disparities in Diagnostic Imaging
Isotretinoin Does Not Up Suicide Risk in Acne Patients
Presence of ctDNA Predicts Worse Outcomes in Early Breast Cancer
Brigatinib Continues to Best Crizotinib in ALK+ Non-Small Cell Lung Cancer
MPR ARTICLES
